Search Within
Applications
Content Type
66825USUPELCO
Applied Filters:
Keyword:'66825USUPELCO'
facet content type:Technical Article
Showing 1-7 of 7 results for "66825USUPELCO" within Site Content
Fast and high-resolution Analysis of Intact Therapeutic Monoclonal Antibody Trastuzumab using BIOshell™ A400 Protein C4 Column
Optimization of a Reversed-Phase Liquid Chromatographic (RP-LC) method for the intact analysis of a therapeutic monoclonal antibody, trastuzumab, using a BIOshell™ A400 Protein C4 column.
Difluoroacetic Acid as an Effective Mobile Phase Modifier for the LC-UV/MS Analysis of Proteins
The article describes the use of difluoroacetic acid (DFA) as an effective alternative to acid modifiers, formic acid (FA) and trifluoroacetic acid (TFA) in the LC-UV/MS analysis of proteins.
Middle Up Mass Analysis Using Trastuzumab as Model Protein
A RPLC-MS workflow for mass analysis of reduced monoclonal antibody, trastuzumab, including reduction procedures, calibration, and system suitability tests.
Biosimilar Comparability Workflow for Intact Mass Analysis
A RPLC-MS workflow for mass analysis of non-reduced monoclonal antibody, trastuzumab, including calibration, and system suitability tests.
Protein Fingerprinting of a Viral Vector, AAV5
Method development for protein fingerprinting of AAV serotype 5
using both intact mass analysis and peptide mapping, to determine critical quality attributes for gene therapy, utilizing three different columns.
BIOshell™ A400 Protein C4 U/HPLC Columns
BIOshell™ A400 Protein C4 columns contain 3.4 μm particles with 400 Å pores, which are derivatized with dimethylbutyl silane and exhaustively endcapped for optimum protein recovery.
HPLC Analysis of Protein Standards (1) on BIOshell™ A400 Protein C4
For use as a marker in SDS-PAGE; Albumin from chicken egg white, For use as a marker in SDS-PAGE; L-Lactic Dehydrogenase from rabbit muscle, Type XI, lyophilized powder, 600-1,200 units/mg protein